Oncodesign, Covalab, CheMatech and ABX-CRO launch DRIVE™-MRT
A premium complete, integrated service offer for radiopharmaceuticals drug discovery and generation
Scientific resources
Scientific publications
Service
Service
Service
Service
Oncodesign
- Service
- Biotech
- Artificial intelligence
- Innovation technologies
- Homing program
- About us
- Contact us
Search
Drug Discovery Service
Integrated or stand alone Drug Discovery services (from hit findings to IND), to discover and evaluate the therapies of tomorrow together.
Participate in research and development programs
Value creation through innovative technologies & R&D partnerships
Parkinson’s disease: Servier and Oncodesign announce the selection of a preclinical candidate
Initiated in March 2019, this Research and Development partnership is focused on the identification of LRRK2 kinase inhibitors derived from Oncodesign’s proprietary Nanocyclix® platform and their potential to act as therapeutic agents against Parkinson’s disease, drawing on Servier and Oncodesign’s complementary expertise in the field of neurodegenerative disease and kinase inhibitors.
Artificial intelligence for therapeutic innovation
For Oncodesign, artificial intelligence (AI) is a powerful tool for accelerating and making drug development more reliable.
Data use for Drug Discovery: InterSystems and Oncodesign Join Forces
Optimization of data use to enhance and accelerate Drug Discovery processes in oncology
Our innovation technologies, a continuum from the molecule to the patient
For more than 25 years, Oncodesign has been investing in precision medicine innovation technologies, which are essential from the very first stages of the Drug Discovery process.
Oncodesign, experts in precision medicine
Oncodesign’s mission is to discover new innovative therapies that are effective against cancers and serious diseases with no known treatments.